Why The FDA’s ‘Breakthrough’ Nomination For MDMA Matters

You may have heard that the U.S. Food and Drug Administration recently designated MDMA a ‘breakthrough therapy’—but what the heck does that mean?   Currently, the Multidisciplinary Association for Psychedelic Studies is studying MDMA for its usefulness in treating extreme post-traumatic stress disorder (PTSD) in conjunction with psychotherapy. They are now entering Phase III clinical […]

Continue Reading

The Middle Age Trip: Musings on Midlife Psychedelic Use and Psychotherapy with Neal M. Goldsmith, Ph.D.

You don’t have to be a wide-eyed millennial to have a mind-opening and life-changing experience with psychedelics. As the media coverage and scientific validity of psychedelics continues to expand, a growing number of middle aged and senior adults are taking note, and some of them are taking the leap of faith into experiencing it for […]

Continue Reading

MDMA By Any Other Name: How Street Names Harm the Reputation of Psychedelic Therapy

The media currently seems to be filled with two types of stories about ecstasy. In some stories, ecstasy is described as a seductive drug that captivates youth dance culture and seduces innocent young people into dangerous situations. These stories tell about unaware party-goers who purchase illegal substances, hoping to obtain “ecstasy,” and end up slipping […]

Continue Reading